Skip to main content
. 2021 Jul 15;13(7):8126–8133.

Table 5.

The incidence of adverse reactions in the two groups (n, %)

Group Control group (n=58) Observation group (n=58) χ2 P
Severe diarrhea 2 (3.45) 1 (1.72) 0.342 0.558
Bedsore 6 (10.34) 1 (1.72) 3.800 0.051
Urinary tract infection 6 (10.34) 1 (1.72) 1.214 0.213
Hepatic and renal impairment 1 (1.72) 1 (1.72) 0.000 1.000
Allergic skin reaction 0 (0.00) 1 (1.72) 1.008 0.315
Total adverse reactions 15 (25.86) 5 (8.62) 6.041 0.014